The mechanisms and roles of selective autophagy in mammals

JNS Vargas, M Hamasaki, T Kawabata… - … reviews Molecular cell …, 2023 - nature.com
Autophagy is a process that targets various intracellular elements for degradation.
Autophagy can be non-selective—associated with the indiscriminate engulfment of cytosolic …

Ubiquitination of non-protein substrates

J Sakamaki, N Mizushima - Trends in Cell Biology, 2023 - cell.com
The covalent attachment of ubiquitin is a common regulatory mechanism in various proteins.
Although it has long been thought that the substrates of ubiquitination are limited to proteins …

Decoding the molecular mechanism of selective autophagy of glycogen mediated by autophagy receptor STBD1

Y Zhang, Y Sun, J Shi, P Xu, Y Wang, J Liu… - Proceedings of the …, 2024 - pnas.org
Autophagy of glycogen (glycophagy) is crucial for the maintenance of cellular glucose
homeostasis and physiology in mammals. STBD1 can serve as an autophagy receptor to …

Influence of intermittent fasting on autophagy in the liver

YN Ma, X Jiang, W Tang, P Song - BioScience Trends, 2023 - jstage.jst.go.jp
Studies have found that intermittent fasting (IF) can prevent diabetes, cancer, heart disease,
and neuropathy, while in humans it has helped to alleviate metabolic syndrome, asthma …

[HTML][HTML] Cell-type specific role of autophagy in the liver and its implications in non-alcoholic fatty liver disease

S Raza, S Rajak, R Singh, J Zhou… - World journal of …, 2023 - ncbi.nlm.nih.gov
Autophagy, a cellular degradative process, has emerged as a key regulator of cellular
energy production and stress mitigation. Dysregulated autophagy is a common …

The hepatoprotective effects of n3-polyunsaturated fatty acids against non-alcoholic fatty liver disease in diabetic rats through the FOXO1/PPARα/GABARAPL1 …

NM Ramadan, K Elmasry, HRH Elsayed, A El-Mesery… - Life sciences, 2022 - Elsevier
Aim We compared the efficacy of n3-polyunsaturated fatty acids (n3-PUFAs) and metformin
in halting the progression of non-alcoholic fatty liver disease (NAFLD) developed in the …

Defect in degradation of glycogenin‐exposed residual glycogen in lysosomes is the fundamental pathomechanism of Pompe disease

N Zhang, F Liu, Y Zhao, X Sun, B Wen… - The Journal of …, 2024 - Wiley Online Library
Pompe disease is a lysosomal storage disorder that preferentially affects muscles, and it is
caused by GAA mutation coding acid alpha‐glucosidase in lysosome and glycophagy …

Targeting autophagy drug discovery: Targets, indications and development trends

M Jiang, W Wu, Z Xiong, X Yu, Z Ye, Z Wu - European Journal of Medicinal …, 2024 - Elsevier
Autophagy plays a vital role in sustaining cellular homeostasis and its alterations have been
implicated in the etiology of many diseases. Drugs development targeting autophagy began …

[HTML][HTML] Neurological glycogen storage diseases and emerging therapeutics

M Colpaert, PK Singh, KJ Donohue, NT Pires… - …, 2024 - Elsevier
Glycogen storage diseases (GSDs) comprise a group of inherited metabolic disorders
characterized by defects in glycogen metabolism, leading to abnormal glycogen …

Targeting autophagy by antipsychotic phenothiazines: potential drug repurposing for cancer therapy

RM Lopes, ACS Souza, M Otręba… - Biochemical …, 2024 - Elsevier
Cancer is recognized as the major cause of death worldwide and the most challenging
public health issues. Tumor cells exhibit molecular adaptations and metabolic reprograming …